ANGPT2 and neoplasm: Ang-2 overexpression due to VEGFR2 blockade increases tumor-associated macrophages (TAMs) infiltration and leads to therapeutic failure, suggesting the reshaping of the tumor immune microenvironment toward pro-tumoral phenotypes.